As of September 24, 2023, around 50 million people in Italy have completed the regular vaccination cycle against COVID-19, corresponding to roughly 85 percent of the total population. In the age group 80 years and older, the one most vulnerable to the virus, this figure reached almost 96 percent. A vaccine for kids under 12 years of age became available only in December 2021. To build a better protection against the virus over time, the Italian authorities started administering a third vaccine dose during autumn 2021, and a fourth dose in spring 2022. So far, roughly three out of four Italians over 12 years of age have received a booster shot. More statistics and facts about the virus in Italy are available here.For a global overview on the various COVID-19 vaccines' development and distribution, visit Statista's Facts and Figures on the topic.

During autumn 2021, Italian authorities started administering booster shots of coronavirus vaccines to the population in order to improve the general protection against the virus, using either Pfizer or Moderna vaccines. As of September 24, 2023, approximately 70.3 percent of the population over 12 years old have received a booster vaccination. This statistic shows regional differences in these figures. Lombardy was the region achieving the highest booster vaccination coverage, with around 74.3 percent. Conversely, just 61.5 percent of citizens living in Sicily received a third shot. About 85 percent of the total population in Italy has completed the regular vaccination cycle, having received two shots. Thanks to this, despite the high number of daily cases, figures for deaths and hospitalizations remain low. More statistics and facts about the virus in Italy are available here.For a global overview on the various COVID-19 vaccines' development and distribution, visit Statista's Facts and Figures on the topic.

View daily updates and historical trends for Italy Coronavirus Vaccination Rate: Any Dosage. Source: Our World in Data. Track economic data with YCharts a…

The flu vaccination coverage in Italy during the flu season ********* varied greatly based on the age group. According to the data, around **** percent of individuals aged 65 years and older got vaccinated against the flu. The Italian region with the highest rate of elderly people who received the flu vaccination was Umbria, with almost ** percent of people over 65 years receiving the vaccine. Coverage rates for all other age groups were much lower. For instance, only around **** percent of individuals aged between 45 and 64 years were vaccinated. Overall, **** percent of Italians were vaccinated against the flu in the period under consideration. Flu vaccination among the elderly As shown by this statistic, people over 65 years are the ones who had the highest flu vaccination rate in Italy during the flu season *********. This group is among those recommended by the Italian Ministry of Health to get vaccinated against seasonal flu. Several countries in the OECD have a higher flu vaccination coverage than Italy. For example, in Korea over ** percent of elderly people had received an influenza vaccination in 2021. Vaccination over time Influenza viruses change often and for this reason, the vaccination must be repeated every year. In Italy, the percentage of people getting vaccinated against seasonal flu during the last two decades varied greatly. Especially with the outbreak of COVID-19, in 2020 there was a steep increase in people getting vaccinated against influenza. Indeed, between 2020 and 2021, around **** percent of people received a flu vaccination, while the year before this rate amounted to **** percent.

Forecast: Total Influenza Vaccination Rates in Italy 2022 - 2026 Discover more data with ReportLinker!

Italy IT: Immunization: Measles: % of Children Aged 12-23 Months data was reported at 85.000 % in 2016. This stayed constant from the previous number of 85.000 % for 2015. Italy IT: Immunization: Measles: % of Children Aged 12-23 Months data is updated yearly, averaging 84.000 % from Dec 1990 (Median) to 2016, with 27 observations. The data reached an all-time high of 91.000 % in 2010 and a record low of 43.000 % in 1990. Italy IT: Immunization: Measles: % of Children Aged 12-23 Months data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Italy – Table IT.World Bank: Health Statistics. Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.; ; WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).; Weighted average;

The number of COVID-19 vaccination doses administered per 100 people in Italy rose to 244 as of Oct 27 2023. This dataset includes a chart with historical data for Italy Coronavirus Vaccination Rate.

During winter 2023-2024, about **** percent of the Italian population was vaccinated against the flu. This statistic highlights regional differences in this figure. According to the data, the regions with the highest coverage rates were Liguria, Tuscany, and Umbria. Conversely, the Autonomous province of Bolzano recorded the lowest rate in the country.

Forecast: Diphtheria, Tetanus and Pertussis Vaccination Rates Among Children in Italy 2022 - 2026 Discover more data with ReportLinker!

During spring 2022, Italian authorities started administering a second booster shot of COVID-19 vaccines to the population in order to improve the general protection against the virus. As of November 20, 2023, approximately 6.7 million Italian citizens have received a booster shot, corresponding to roughly 11.4 percent of the population over five years old. This statistic breaks down these figures by age of the vaccinated. In the age group 80+, the one most vulnerable to the virus, over 45.6 percent of the individuals received a fourth shot.

About 85 percent of the total population in Italy has completed the regular vaccination cycle, having received two shots. Moreover, three out of four Italians over 12 years of age have received a third shot. Thanks to this, despite the high number of daily cases, figures for deaths and hospitalizations remain low.

More statistics and facts about the virus in Italy are available here. For a global overview on the various COVID-19 vaccines' development and distribution, visit Statista's Facts and Figures on the topic.

Actual value and historical data chart for Italy Immunization Measles Percent Of Children Ages 12 23 Months

Despite the well-recognized role of vaccines, coverage is far from optimal especially in children, representing a growing concern also in Italy. In order to reverse this emergency, the Italian Ministry approved in July 2017 the Law 119/2017, which renders mandatory and free of charge 10 vaccinations for patients aged 0–16. We aim to investigate the effects of the new Law 119/2017 on the reporting of adverse events following immunization related to mandatory vaccines into the Italian Pharmacovigilance database (Rete Nazionale di Farmacovigilanza – RNF). Therefore, we analyzed the spontaneous reports of suspected adverse events following immunization recorded in Campania Region (South of Italy) from December 1, 2016, to March 31, 2018. During the study period, 69 reports, covering 179 AEFIs, related to mandatory vaccines were sent to Campania Pharmacovigilance Regional Center. A substantial increase in AEFIs reporting was observed after the adoption of Law 119/2017. Out of 69 reports, 62% reported AEFIs that were considered as not serious and 78% had a favorable outcome. Out of 179 AEFIs, more than half referred to the following SOC: “general disorders and administration site conditions,” “nervous system disorders,” and “psychiatric disorders.” The highest number of reports came from patient/citizen. After the adoption of the Law 119/2017, there was an increase in the number of reports (18 before the adoption of the Law vs. 51 after). According to reported AEFIs during the entire period, no worrying safety data have emerged. In our opinion, the increase in the number of AEFIs’ reports should be related to the increase in vaccination coverage as well as to the intense debate that has followed the new Law. In this context, the continuous monitoring of vaccine safety and the fully implementation of vaccine–vigilance programs play a key role in achieving higher confidence in immunization programs and optimal vaccination coverage rate.

As of 2023, coverage of the measles vaccine among children in birth-cohort 2021 in Italy was equal to roughly **** percent. According to the data, the region of Autonomous Province of Bolzano registered the lowest vaccination coverage nationwide, with **** percent of two-year-old children vaccinated. This statistic shows the coverage rate of the measles vaccine among two-year-old children in Italy as of 2023, by region.

The number of COVID-19 vaccination doses administered in Italy rose to 143854436 as of Oct 27 2023. This dataset includes a chart with historical data for Italy Coronavirus Vaccination Total.

Actual value and historical data chart for Italy Immunization Dpt Percent Of Children Ages 12 23 Months

Introduction: In 2021, the European Medicines Agency supported the “Covid Vaccine Monitor (CVM),” an active surveillance project spanning 13 European countries aimed at monitoring the safety of COVID-19 vaccines in general and special populations (i.e., pregnant/breastfeeding women, children/adolescents, immunocompromised people, and people with a history of allergies or previous SARS-CoV-2 infection). Italy participated in this project as a large multidisciplinary network called the “ilmiovaccinoCOVID19 collaborating group.”Methods: The study aimed to describe the experience of the Italian network “ilmiovaccinoCOVID19 collaborating group” in the CVM context from June 2021 to February 2023. Comprising about 30 partners, the network aimed to facilitate vaccinee recruitment. Participants completed baseline and follow-up questionnaires within 48 h from vaccination over a 6-month period. Analyses focused on those who completed both the baseline and the first follow-up questionnaire (Q1), exploring temporal trends, vaccination campaign correlation, and loss to follow-up. Characteristics of recruited vaccinees and vaccinee-reported adverse drug reactions (ADRs) were compared with passive surveillance data in Italy.Results: From June 2021 to November 2022, 22,384,663 first doses and 38,207,452 booster doses of COVID-19 vaccines were administered in Italy. Simultaneously, the study enrolled 1,229 and 2,707 participants for the first and booster doses, respectively. Of these, 829 and 1,879 vaccinees, respectively, completed both baseline and at least Q1 and were included in the analyses, with a significant proportion of them (57.8%/34.3%) belonging to special cohorts. Most vaccinees included in the analyses were women. Comirnaty® (69%) and Spikevax® (29%) were the most frequently administered vaccines. ADR rates following Comirnaty® and Spikevax® were higher after the second dose, particularly following Spikevax®. Serious ADRs were infrequent. Differences were observed in ADR characteristics between CVM and Italian passive surveillance.Conclusion: This study confirmed the favorable safety profile of COVID-19 vaccines, with findings consistent with pivotal clinical trials of COVID-19 vaccines, although different proportions of serious ADRs compared to spontaneous reporting were observed. Continuous evaluation through cohort event monitoring studies provides real-time insights crucial for regulatory responses. Strengthening infrastructure and implementing early monitoring strategies are essential to enhance vaccine safety assessment and prepare for future pandemics.

Actual value and historical data chart for Italy Immunization Pol3 Percent Of One Year Old Children

Among non mandatory vaccines, the vaccination rate against meningococcus C and ACYW was the one registering the biggest increase between 2016 and 2018 in Italy. According to data, the coverage against this disease increased by ***** percent for children in birth cohort 2015 compared to those in birth cohort 2014. In addition, the vaccination rate against meningococcus B increased by ***** percent.

Invasive meningococcal disease is a life-threatening infection preventable through vaccination. Pediatric vaccination rates have declined during the coronavirus disease 2019 (COVID-19) pandemic. This survey aimed to understand how parents’ attitudes and behaviors have changed during the pandemic with regard to immunization and, more specifically, meningococcal vaccination. An online survey was emailed to parents of eligible children 0–4 years, following the selection process from UK, France, Germany, Italy, Brazil, Argentina, and Australia; and of adolescents 11–18 years from US. Data collection took place 19 January–16 February 2021. Quotas were set to ensure a representative sample. Eleven questions relating to general perceptions around vaccination and attitudes and behaviors toward meningitis vaccination were displayed. On 4,962 parents (average 35 years) participating in the survey, most (83%) believed important for their child to continue receiving recommended vaccines during the COVID-19 pandemic. Nearly half of routine vaccine appointments were delayed or canceled due to the pandemic, and 61% of respondents were likely to have their children catch up once COVID-19 restrictions were lifted. 30% of meningitidis vaccination appointments were canceled or delayed during the pandemic, and 21% of parents did not intend to reschedule them because of lockdown/stay at home regulations, and fear of catching COVID-19 in public places. It is crucial to communicate clear instructions to health workers and the general population and to provide appropriate safety precautions in vaccination centers. This will help to maintain vaccination rates and limit infections to prevent future outbreaks. What is the context?Invasive meningococcal disease (IMD) is an uncommon infection that can lead to permanent disabilities and even death.Meningitis vaccination can prevent IMDs caused by Neisseria meningitidis.Vaccination rates have declined during the coronavirus (COVID-19) pandemic. Invasive meningococcal disease (IMD) is an uncommon infection that can lead to permanent disabilities and even death. Meningitis vaccination can prevent IMDs caused by Neisseria meningitidis. Vaccination rates have declined during the coronavirus (COVID-19) pandemic. What is new?We collected opinion of parents from the UK, France, Germany, Italy, Brazil, Argentina, Australia, and the US, to understand their attitudes and behaviors toward meningitis vaccination during the COVID-19 pandemic.Results were reviewed by health care professional experts as well as by patient authors (IMD survivors).Most (83%) of the 4,962 parents believed that it is important for their child to continue receiving recommended vaccines during the COVID-19 pandemic.Half of the scheduled appointments for meningitis vaccination were canceled or delayed during the COVID-19 pandemic, mainly due to lockdown regulations and fear of catching COVID-19.Twenty-one percent of the parents who had their child’s meningitis vaccination appointment canceled, did not intend to reschedule it. We collected opinion of parents from the UK, France, Germany, Italy, Brazil, Argentina, Australia, and the US, to understand their attitudes and behaviors toward meningitis vaccination during the COVID-19 pandemic. Results were reviewed by health care professional experts as well as by patient authors (IMD survivors). Most (83%) of the 4,962 parents believed that it is important for their child to continue receiving recommended vaccines during the COVID-19 pandemic. Half of the scheduled appointments for meningitis vaccination were canceled or delayed during the COVID-19 pandemic, mainly due to lockdown regulations and fear of catching COVID-19. Twenty-one percent of the parents who had their child’s meningitis vaccination appointment canceled, did not intend to reschedule it. What is the impact?It is crucial that clear information is communicated by health care authorities and practitioners about the availability of vaccination during pandemic and the safety precautions that are taken.Collected opinions emphasize the importance of continuing vaccinations against infectious diseases during a pandemic. It is crucial that clear information is communicated by health care authorities and practitioners about the availability of vaccination during pandemic and the safety precautions that are taken. Collected opinions emphasize the importance of continuing vaccinations against infectious diseases during a pandemic.

During the COVID-19 vaccination campaign in 2023 and 2024 in Italy, which started in October 2023, the highest share of vaccines were given to people aged 80 years and older, with 32.5 percent. Conversely, people aged 60 years and younger, received only 14.9 percent of the total vaccinations provided in this period. This statistic displays the distribution of COVID-19 vaccinations in Italy during the 2023/2024 vaccination campaign as of September 2024, by age group.